Melanotan II on TikTok: tanning peptide or risky experiment?

What did @coachkatie.rogers actually say?

She laid out a pretty structured breakdown of melanotan II, covering what she called the "pros, cons, what to expect" and walking through a specific dosing protocol she plans to follow herself. She correctly flagged libido increase, appetite suppression, flushing, nausea, and fatigue as known effects. Most notably, she mentioned that "the number one thing to watch out for is melanoma risk" and told viewers with existing moles or family history to get checked frequently. She described a loading phase starting at 0.5 mg daily for seven to fourteen days, followed by a maintenance schedule of 0.5 to 1 mg two to three times per week. She also distinguished MT-1 from MT-2, characterizing MT-1 as slower and safer and MT-2 as faster and stronger. The framing is casual and personal-journey-coded, which matters for how audiences receive it.

Does the science back this up?

The short answer is: some of it, but the safety framing is dangerously incomplete. Melanotan II is a synthetic analog of alpha-melanocyte-stimulating hormone. The effects she describes, including tanning, appetite suppression, and libido changes, are pharmacologically real and documented. The risk picture, however, is much darker than her video suggests.

A 2011 case series published in the Journal of the American Academy of Dermatology (Langan et al.) documented multiple cases of rapid and atypical melanocytic lesion changes following melanotan II use. A 2019 review in Clinical and Experimental Dermatology (Habbema et al.) found that MT-2 stimulates existing melanocytes indiscriminately, potentially accelerating changes in atypical nevi that could progress toward malignancy. The libido effect is tied to MC4 receptor agonism and is well-documented in human trials (Wessells et al., 2000, International Journal of Impotence Research). The appetite suppression pathway through MC4R is also established in rodent and early human data. So on mechanism, she is not wrong. On the risk hierarchy, she undersells the concern significantly.

What did they get wrong (or right)?

She got the side effect list broadly right. Flushing, nausea, fatigue, and appetite changes are consistently reported in the literature and in pharmacovigilance data. Credit where it is due: she did not claim MT-2 is safe or approved, and she explicitly named melanoma risk, which many creators skip entirely.

Where she went wrong is more serious. First, MT-2 is not approved by the FDA or EMA for any indication. It is not a licensed medicine. Framing it as a peptide you simply "start" with a loading phase normalizes use of an unapproved substance without acknowledging that its quality, purity, and dosing consistency are entirely unregulated. Second, her framing that more moles appearing is something "a lot of people have noticed" treats a potential warning sign as a routine cosmetic outcome. New or changing moles following MT-2 use are a documented dermatological red flag, not a side note. Third, the suggestion that watching your moles and getting checked "frequently" is a sufficient mitigation strategy for someone with family history of melanoma is not clinically adequate advice. Those individuals probably should not be using this compound at all.

What should you actually know?

MT-2 has no approved medical use in the United States, United Kingdom, or European Union. It is classified as a research chemical, and any product sold as MT-2 for human use exists in a regulatory gray zone with no quality controls. That means what is in the vial, the actual concentration, sterility, and purity, is unverified.

The melanoma risk is not just about watching your moles. A 2019 report from the UK Medicines and Healthcare products Regulatory Agency (MHRA) issued a safety warning specifically about tanning injections including melanotan II, citing links to melanoma and blood pressure changes. The MHRA warning was not a soft advisory; it recommended against use outright. The concern is not only that MT-2 darkens skin, it is that it activates melanocyte receptors systemically and non-selectively, which could theoretically accelerate malignant transformation in predisposed cells. Getting a dermatology check every few months does not neutralize that biological process. Finally, libido effects and the cardiovascular side effects including hypertension and tachycardia noted in case reports (Nelson et al., 2012, BMJ Case Reports) are absent from her rundown. Those omissions matter when viewers are making decisions.